Eupraxia Pharmaceuticals Inc. (EPRX)

NASDAQ: EPRX · Real-Time Price · USD

6.94

+0.57 (8.95%)

At close: May 21, 2026, 4:00 PM EDT

7.06

+0.12 (1.73%)

After-hours: May 21, 2026, 6:20 PM EDT

Eupraxia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	58.5	80.56	33.1	19.34	18.26	16.51
Short-Term Investments	80.38	-	-	-	-	7.12
Cash & Short-Term Investments	138.88	80.56	33.1	19.34	18.26	23.63
Cash Growth	405.85%	143.39%	71.14%	5.91%	-22.70%	19954.27%
Other Receivables	0.66	0.67	0.23	0.19	0.09	0.34
Receivables	0.66	0.67	0.23	0.19	0.09	0.34
Prepaid Expenses	2.58	3.86	1.11	0.27	0.24	0.21
Total Current Assets	142.13	85.1	34.44	19.8	18.59	24.18
Property, Plant & Equipment	3.17	0.99	0.42	0.46	0.53	0.47
Other Long-Term Assets	0.06	0.06	0.08	0.01	0	0.02
Total Assets	145.35	86.15	34.94	20.27	19.12	24.67
Accrued Expenses	-	5.51	3.01	3.87	2.91	1.67
Current Portion of Long-Term Debt	-	-	-	10.4	0.08	0.08
Current Portion of Leases	0.2	0.08	0.07	0.05	0.05	0.05
Current Income Taxes Payable	-	0	-	0.04	-	-
Other Current Liabilities	-	0.04	0.02	5.02	0.02	0
Total Current Liabilities	7.36	5.63	3.1	19.37	3.06	1.79
Long-Term Debt	-	-	-	-	8.8	7.66
Long-Term Leases	1.8	0.08	-	-	0.05	0.11
Total Liabilities	9.17	5.7	3.1	19.37	11.91	9.56
Common Stock	255.5	195.41	116.36	92.91	71	61.36
Additional Paid-In Capital	39.27	28.52	20.5	17.51	16.85	-
Retained Earnings	-182.23	-169.58	-131	-105.5	-77.28	-58.68
Comprehensive Income & Other	-4.48	-2.04	-4.16	-2.71	-2.79	13.09
Total Common Equity	108.05	52.3	1.7	2.22	7.79	15.77
Minority Interest	-1.6	-1.6	-1.57	-1.32	-0.58	-0.66
Shareholders' Equity	136.19	80.45	31.84	0.89	7.21	15.11
Total Liabilities & Equity	145.35	86.15	34.94	20.27	19.12	24.67
Total Debt	2.01	0.15	0.07	10.45	8.99	7.9
Net Cash (Debt)	136.87	80.41	33.03	8.89	9.28	15.73
Net Cash Growth	399.50%	143.45%	271.55%	-4.18%	-41.03%	-
Net Cash Per Share	3.03	2.01	0.97	0.37	0.48	1.27
Filing Date Shares Outstanding	61.81	61.5	35.85	35.62	27.36	14.24
Total Common Shares Outstanding	61.81	51.94	35.64	27.28	21.59	14.24
Working Capital	134.76	79.47	31.33	0.43	15.53	22.39
Book Value Per Share	1.75	1.01	0.05	0.08	0.36	1.11
Tangible Book Value	108.05	52.3	1.7	2.22	7.79	15.77
Tangible Book Value Per Share	1.75	1.01	0.05	0.08	0.36	1.11
Buildings	-	-	-	-	-	0.07
Machinery	-	1.35	0.7	0.68	0.61	0.1
Leasehold Improvements	-	0.13	0.12	0.13	0.13	0.13

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q